14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools

“By lowering the cost of protein medicines,” Baker said, “we’re taking considerable steps toward a future where everyone can get the treatments they deserve”. What once lived in theoretical models now shapes real therapeutics, and the pace looks to be picking up.

A Brief on Protein Structure

Even though proteins weren’t always designed, they still ran the cell’s command center. Made from 20 alpha-amino acids, they assemble into enzymes, receptors, scaffolds, and transporters. Each function traces back to a linear amino acid sequence, which determines how the chain folds. The origin of proteins likely lies in early Earth’s prebiotic chemistry, though the exact path from primordial soup to functional polymer remains unsettled.

The first classification attempts appeared in the late 1700s. In 1789, Antoine Fourcroy grouped albumin, fibrin, gelatin, and gluten as members of a broader category then referred to as “albumins”. The word “protein” entered scientific vocabulary in 1838 via Jöns Jacob Berzelius. A century later, structural biology advanced with the 1958 X-ray crystallographic model of myoglobin resolved by John Kendrew, revealing how folded shape governs protein behavior. Just a few years later, scientific illustrator Irving Geis translated this atomic model into a detailed visual form—his 1961 rendering of myoglobin helped establish the visual language of molecular biology and remains one of the earliest acts of protein design by hand.

A protein is shaped hierachically—starting as a chain of amino acids, folding into local patterns like helices and sheets, forming a compact 3D structure, and sometimes joining with other chains to work as a complex:

Protein structures; Source: Recursion/Wiki Commons

Determining these shapes has relied on atomic-resolution techniques—X-ray crystallography, cryo-EM, and NMR. Structural data from these methods, archived in the Protein Data Bank (PDB), not only defined the field of structural biology but now trains AI systems that design proteins from scratch.

From Manual to Computational

For most of the last century, protein design meant hours at the bench and days at the diffraction beamline. Structural biologists tinkered with single residues through site-directed mutagenesis, hoping each swap would clarify how shape controls function. Progress moved by inches and every unexpected result sent teams back to the notebook.

In 1998 Rosetta arrived. A computational suite for macromolecular modeling, developed at Baker Lab, used physics-based energy functions and stochastic search algorithms to predict three-dimensional protein or nucleic-acid structures. Folding pathways could be simulated, energies scored, and entirely synthetic backbones proposed—but each run devoured CPU time and every model still faced wet-lab reality checks.

Unpredictable links between sequence and activity pushed many labs toward directed evolution. Vast mutant libraries, screened in microtiter plates or droplet devices, turned chance into strategy. The approach worked well enough to earn Frances Arnold a share of the 2018 Nobel Prize in Chemistry.

Bench experiments, high-performance computing, evolution—all offered different routes, but all collided with the same obstacle of the time elapsed. Generating, expressing, and validating candidates was a cost sink.

End-to-End AI Workflows